Latest: Ellenbarrie Industrial Gases Ltd Q1 FY27 (Apr–Jun 2026) results →This page is Q3 FY26 (Oct–Dec 2025).All Q3 FY26 results →
EI

Ellenbarrie Industrial Gases Ltd

Q3 FY26Chemicals & Petrochemicals

Ellenbarrie Industrial Gases Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Price₹328
Market cap₹4.0K Cr
P/E37.9
Updated23 Aug 2026
Read4 min read

The short version

Company targets a long-term revenue growth rate of about 20-25% CAGR. Ellenbarrie Industrial Gases Ltd targets a long-term revenue CAGR of 20-25%, driven by new capacity additions across Eastern, Northern, and Western India over FY27-FY28.

From Ellenbarrie Industrial Gases Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Company targets a long-term revenue growth rate of about 20-25% CAGR.
  • Growth will be lumpy, driven by step changes as new capacity plants are commissioned.
  • New plants coming online: Uluberia 2 merchant plant recently commissioned; East India on-site plant expected Q1 FY27; North India bulk plant expected H2 FY27; Western India speciality gases unit targeted FY28.
  • Uluberia 2 ramp-up expected to reach 85% capacity utilization faster than typical 18 months due to existing market presence.
  • Expansion projects totaling around INR 450 crore capex over next couple of years.
  • Long-term growth is tied to both organic capacity increase and entering speciality gases (e.g., solar industry).

2 more points from Ellenbarrie Industrial Gases Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Ellenbarrie Industrial Gases Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Ellenbarrie is undertaking three main projects with a total capex of about ₹450 crores over the next couple of years.
  • Projects include an on-site plant in Eastern India, a merchant plant in Northern India, and a merchant plus specialty gases plant in Western India.
  • The Eastern India on-site plant is expected to be commissioned in Q1 FY27.
  • The Northern India merchant plant is targeted for commissioning in H2 FY27.
  • The Western India specialty gases and merchant plant is expected by FY28.
  • Capex guidance is ₹250 crores in FY26 and ₹200 crores in FY27.

2 more points from Ellenbarrie Industrial Gases Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Ellenbarrie Industrial Gases Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Ellenbarrie Industrial Gases Ltd has ordered new plants as part of their expansion.
  • The North India merchant plant commissioning timeline is set for H2 FY27.
  • Plant orders have been placed, with construction and civil work scheduled around equipment delivery.
  • The company's growth focus includes three key projects: an on-site plant in Eastern India (expected Q1 FY27), a North India merchant plant (H2 FY27), and a Western India merchant plus specialty gases plant (target FY28).

2 more points from Ellenbarrie Industrial Gases Ltd's call on order book

Create a free account to keep reading this call

Ellenbarrie Industrial Gases Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹87 Cr, net profit ₹23 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Neochem Bio (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chem. (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • IVP (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Ellenbarrie Industrial Gases Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Ellenbarrie Industrial Gases Ltd Q3 FY26 results?

Company targets a long-term revenue growth rate of about 20-25% CAGR. Ellenbarrie Industrial Gases Ltd targets a long-term revenue CAGR of 20-25%, driven by new capacity additions across Eastern, Northern, and Western India over FY27-FY28.

What is Ellenbarrie Industrial Gases Ltd share price analysis?

Ellenbarrie Industrial Gases Ltd currently shows a neutral. The stock trades at a P/E of 37.9 with a market cap of ₹3,960 Cr. Investors should review the full earnings analysis for detailed insights.

Is Ellenbarrie Industrial Gases Ltd planning capital expenditure?

Ellenbarrie is undertaking three main projects with a total capex of about ₹450 crores over the next couple of years.

Keep Ellenbarrie Industrial Gases Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.